Polyurethane II catheter as long-indwelling intravenous catheter in patients with cancer

American Journal of Infection Control

Volumn 31, Issue 7, 2003, Pages 392-396

  Volkow, Patricia ^a,b   Vázquez, Carolina ^a   Téllez, Odilia ^a   Aguilar, Catalina ^a   Barrera, Laura ^a   Rodríguez, Eneida ^a   Vilar Compte, Diana ^a   Zinser, Juan ^a   Calderon, Ernesto ^a   Pérez Padilla, José Rogelio ^a   Mohar, Alejandro ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

SILICONE;

ARTICLE; BACTEREMIA; CANCER PATIENT; CARDIOVASCULAR RISK; EMBOLISM; HEMATOMA; HUMAN; INDWELLING CATHETER; INFECTION RISK; MAJOR CLINICAL STUDY; PNEUMOTHORAX; RISK ASSESSMENT; RUPTURE; SUPERIOR CAVA VEIN SYNDROME; THROMBOSIS; VASCULAR ACCESS;

EID: 10744230914     PISSN: 01966553     EISSN: None     Source Type: Journal    
DOI: 10.1067/mic.2003.39     Document Type: Article

References (23)

1. Gravenstein N, Blackshear RH. In vitro evaluation of relative perforating potential of central venous catheters: comparison of materials, selected models, number of lumens, and angles of incidence to simulated membrane. L Clin Monitoring 1991;7:1-6.
2. Stenqvist O, Curelaru I, Linder LE, Gustavsson B. Stiffness of central venous catheters. Acta Anaesthesiol Scan 1983;27:153-7.
3. Linder LE, Curelaru I, Gustavsson B, Hansson HA, Stenqvist O, Wojciechowski J. Material thrombogenicity in central venous catheterization: a comparison between soft antebrachial catheters of silicone elastomer and polyurethane. J Parent Nutr 1984;8:400-6.
4. Zdrahala RJ, Solomon DD, Lentz DJ, McGary CW. Thermoplastic polyurethanes. Materials for vascular catheters. In: Planck H, et al, eds. Polyurethanes in biomedical engineering. II. Amsterdam: Elsevier Science; 1987. p. 1-18.
5. Volkow P, Sanchez-Mejorada P, Lazo S, Vázquez C, Téllez O, Baez RM, et al. Experience of an intravenous therapy team at the Instituto Nacional de Cancerología (Mexico) with a long-lasting, low-cost silastic venous catheter. Can Infect Dis 1994;18:719-25.
6. Kaplan EL, Mieier P. Nonparametric estimation from incomplete observation. J Am Stat Assoc 1958;53:457-81.
7. Simón R. Clinical trials in cancer. In: De Vita V, Hellman S, Rosenberg SA, editors. Cancer principles and practices, 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 321-38.
8. Pessa ME, Howard RJ. Complications of Hickman-Broviac catheter. Surg Gynecol Obstet 1985;161:257-60.
9. Larson EB, Wooding M, Hickman RO. Infectious complications of right atrial catheters used for venous access in patients receiving intensive chemotherapy. Surg Gynecol Obstet 1981;153:369-73.
10. Simmons JR, Buzdar AU, Ota DM, Marts K, Hortobagyi GN. Complications associated with indwelling catheter. Med Pediatr Oncol 1992;20:22-5.
11. Mueller BU, Skelton J, Callender DP, et al. A prospective randomized trial comparing the infectious and noninfectious complications of an externalized catheter versus a subcutaneously implanted device in cancer patients. J Clin Oncol 1992;10:1943-8.
12. Pegues D, Axelrod P, McClarren C, et al. Comparison of infections in Hickman and implanted port catheter in adult solid tumor patients. J Surg Oncol 1992;49:156-62.
13. Simon R. Optimal two-stage designs for phase II clinical trials. Cancer Clin Trials 1989;10:1-7.
14. Groeger JS, Lucas AB, Thaler HT, Friedlander-Klar H, Brown AE, Kiehan TE, Armstrong D. Infectious morbidity associated with long-term use of venous access devices in patients with cancer. Ann Intern Med 1993;119:1168-74.
15. Bach A, Böhrer H, Motsch J, Martin E, Geiss HK, Sonntag HG. Prevention of bacterial colonization of intravenous catheters by antiseptic impregnation of polyurethane polymers. J Antimicrob Chemother 1994;33:969-78.
16. Maki DG, Garman JK, Shapiro JM, Ringer M, Helgerson RB. An attachable silver-impregnated cuff for prevention of infection with central venous catheters: prospective randomized multicenter trial. Am J Med 1988;85:307-14.
17. Flowers RH, Schwenzer KJ, Kopel RF, Fisch MJ, Tucker SI, Farr BM. Efficacy of an attachable subcutaneous cuff for the prevention of intravascular catheter-related infection. JAMA 1989;262:878-83.
18. Norwood S, Hajjar G, Jenkins L. The influence of an attachable subcutaneous cuff for preventing triple lumen catheter infections in critically ill surgical and trauma patients. Surg Gynecol Obstet 1992;175:33-40.
19. Raad I, Darouchi R, Dupuis J, Abi-Said D, Gabrielli A, Hachem R, et al. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, double-blind trial. Ann Intern Med 1997;127:267-74.
20. Maki DG, Stolz SM, Wheeler S, Mermel LA. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized controlled trial. Ann Intern Med 1997;127:257-66.
21. Daoruchi RO, Raad I, Head SO, Thornby JI, Wenker OC, Gabrielli A, et al. A comparison of two antimicrobial-impregnated central venous catheters. N Engl J Med 1999;340:1-8.
22. Raad I, Hachem R, Zermeno A, Stephens LC, Bodey GP. Silver iontophoretic catheter: a prototype of a long-term antiinfective vascular access device. J Infect Dis 1996;173(2):495-8.
23. Keung YK, Watkins K, Chen SC, Groshen S, Silberman H, Douer D. Comparative study of infectious complications of different types of chronic central venous access devices. Cancer 1994;73:2832-7.